The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Updated overall survival (OS) results for BRF113220, a phase I–II study of dabrafenib alone versus combined dabrafenib and trametinib in patients with BRAF V600 metastatic melanoma (MM).
 
Adil Daud
Stock and Other Ownership Interests - Oncosec
Consulting or Advisory Role - GlaxoSmithKline; Merck; Oncosec
Research Funding - Genentech/Roche (Inst); GlaxoSmithKline (Inst); Merck/Schering Plough (Inst); oncosec (Inst); Pfizer (Inst)
 
Jeffrey S. Weber
Stock and Other Ownership Interests - Altor BioScience; Celldex; Merck
Honoraria - Abbvie; Altor BioScience; Amgen; AstraZeneca; Bristol-Myers Squibb; Celldex; Daiichi Sankyo; Eisai; Genentech; GlaxoSmithKline; Ichor Medical Systems; Lion Biotechnologies; Merck; Merck; Pieris Pharmaceuticals; Roche
Consulting or Advisory Role - Abbvie; Altor BioScience; Amgen; AstraZeneca; Bristol-Myers Squibb; Celldex; Daiichi Sankyo; Eisai; Genentech; GlaxoSmithKline; Ichor Medical Systems; Lion Biotechnologies; Merck; Merck; Pieris Pharmaceuticals; Roche
Research Funding - Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Merck (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Bristol-Myers Squibb; Celldex; Daiichi Sankyo; Genentech; GlaxoSmithKline; Lion Biotechnologies; Merck; Merck; Pieris Pharmaceuticals; Roche
 
Jeffrey Alan Sosman
No Relationships to Disclose
 
Kevin Kim
Stock and Other Ownership Interests - GlaxoSmithKline
Honoraria - GlaxoSmithKline
 
Rene Gonzalez
Honoraria - Amgen; Bristol-Myers Squibb; Genentech; Roche Pharma AG
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Genentech; Roche Pharma AG
Research Funding - Amgen (Inst); Castle Biosciences (Inst); GlaxoSmithKline (Inst); Merck (Inst); Piramal Life Science (Inst); Roche Pharma AG (Inst)
 
Omid Hamid
Speakers' Bureau - GlaxoSmithKline
Research Funding - GlaxoSmithKline (Inst)
 
Jeffrey R. Infante
Consulting or Advisory Role - GlaxoSmithKline (Inst)
Research Funding - GlaxoSmithKline (Inst)
 
Jonathan S. Cebon
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; Novartis
Consulting or Advisory Role - Amgen (Inst); Bionomics (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Merck Sharp & Dohme (Inst); Merck Sharp & Dohme (Inst)
Research Funding - CSL Behring (Inst); GlaxoSmithKline (Inst)
Patents, Royalties, Other Intellectual Property - GlaxoSmithKline
 
Lynn Mara Schuchter
Research Funding - Bristol-Myers Squibb (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Merck (Inst); Roche (Inst)
 
Georgina V. Long
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; MERCK; Novartis; Provectus; Roche/Genentech
Travel, Accommodations, Expenses - Roche/Genentech
 
Alain Patrick Algazi
Research Funding - Amgen; AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; Merck; Novartis; OncoSec
 
Ragini Reiney Kudchadkar
Honoraria - Bristol-Myers Squibb; Genentech
Consulting or Advisory Role - Bristol-Myers Squibb; Genentech
Speakers' Bureau - Bristol-Myers Squibb; Genentech
 
Igor Puzanov
No Relationships to Disclose
 
Donald P. Lawrence
No Relationships to Disclose
 
Richard Kefford
Honoraria - Merck; Novartis; Roche Pharma AG
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Merck; Novartis; Roche Pharma AG
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck
 
Amy S. Kline
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Heather Lynn Del Buono
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
Research Funding - GlaxoSmithKline
 
Peng Sun
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Diane Opatt McDowell
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
Other Relationship - GlaxoSmithKline
 
Keith Flaherty
Stock and Other Ownership Interests - Clovis Oncology; Loxo
Consulting or Advisory Role - Amgen; Genentech; GlaxoSmithKline; Lilly; Merck; Momenta Pharmaceuticals; Novartis; Oncoceutics; Sanofi; Viralytics; ZIOPHARM Oncology
Research Funding - Novartis; Sanofi
Travel, Accommodations, Expenses - GlaxoSmithKline; Sanofi